查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球糖尿病性黄斑水肿治疗市场：增长、未来展望、竞争分析 (2022-2030)
市场调查报告书
商品编码
1167503

全球糖尿病性黄斑水肿治疗市场：增长、未来展望、竞争分析 (2022-2030)

Diabetic Macular Edema Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

糖尿病性黄斑水肿是糖尿病性视网膜病变患者的一种并发症，这种疾病的视网膜黄斑部血管受损，液体渗出。 有两种主要类型的疾病及其治疗：通过手术治疗的局部黄斑水肿和通过药物治疗的瀰漫性黄斑水肿。 光凝激光疗法被用作视力模糊和復视患者的标准治疗方案。 此外，自 2005 年以来，抗 VEGF 药物治疗一直被认为是糖尿病性黄斑水肿的一线治疗方法，因为它可以抑制 VEGF 的各种亚型，从而提高视力和预防失明。

本报告分析了全球糖尿病性黄斑水肿治疗市场，包括市场基本结构、宏观和微观环境因素、整体市场规模趋势展望（2020-2030 年）、治疗方法等详细趋势我们将通过法律和地区、主要市场驱动和製约因素、主要公司的概况和增长战略。

内容

第一章介绍

第 2 章执行摘要

第 3 章糖尿病性黄斑水肿治疗市场：竞争分析

  • 糖尿病黄斑水肿治疗市场：主要供应商的市场定位
  • 供应商在糖尿病黄斑水肿治疗市场采用的策略
  • 主要行业战略
  • 层次分析 (2021/2030)

第 4 章糖尿病性黄斑水肿治疗市场：宏观分析和市场动态

  • 介绍
  • 世界糖尿病性黄斑水肿治疗市场规模（单位：百万美元，2020-2030 年）
  • 市场动态
    • 市场驱动力
    • 市场製约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析

第 5 章糖尿病性黄斑水肿治疗市场：按治疗（单位：百万美元，2020-2030）

  • 市场概览
  • 增长和收益分析 (2021/2030)
  • 市场细分
    • 药物
    • 手术
    • 管道分析

第 6 章北美糖尿病性黄斑水肿治疗市场（单位：百万美元，2020-2030 年）

  • 市场概览
  • 糖尿病性黄斑水肿治疗市场：按治疗分类（单位：百万美元，2020-2030 年）
  • 按地区分列的糖尿病性黄斑水肿治疗市场（单位：百万美元，2020-2030 年）
    • 北美

第 7 章英国和欧盟国家的糖尿病性黄斑水肿治疗市场（单位：百万美元，2020-2030 年）

第 8 章亚太地区糖尿病性黄斑水肿治疗市场（单位：百万美元，2020-2030 年）

第 9 章拉丁美洲糖尿病性黄斑水肿治疗市场（单位：百万美元，2020-2030 年）

第 10 章中东和非洲糖尿病性黄斑水肿治疗市场（单位：百万美元，2020-2030 年）

第11章公司简介

  • Allergan, Inc.
  • Alimera Sciences
  • Bausch and Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Ellex
  • Genetech, Inc.
  • IRIDEX Corporation
  • LUMENIS
  • Novartis AG
  • Quantel-Medical
  • Regeneron Pharmaceuticals, Inc.
Product Code: 137931-08-22

World Health Organization 2018 survey states that globally around 422 million people suffer with diabetes and approximately 2.6 % of the global blindness is due to diabetic retinopathy. The American Academy of Ophthalmology has stated that the incidence rate of diabetic macular edema in a span of 10 years to be 20 % in younger patients and 40 % in older patients. Currently combined therapy of photocoagulation laser therapy and Anti-VEGF drugs are employed to achieve improved vision and avoid blindness. The drugs in phase III clinical trials such as conbercept, pemofibrate, ranibizumab and aflibercept intravitreal injection are tested for better drug efficacy.

Therapy segment for the diabetic macular edema treatment market majorly comprises drugs and surgery. The drugs are further sub segmented as Anti-VEGF, Corticosteroids and other drugs (Triamcinolone Acetonide and Bevacizumab). Anti-VEGF treatment adopted is Ranibizumab and Aflibercept. Corticosteroids includes dexamethasone and Fluocinolone Acetonide. The surgery segment comprises of photocoagulation laser therapy and intravitreal implants. In order to understand the current trend existing in the market the data forecast and market estimation for treatment segment is given in the scope of the report.

Competitive landscape is an assessment tool highlights the performance of the fundamental players currently engaged in the diabetic macular edema treatment market. The parameters employed are geographical presence, product portfolio and inception. Company profiles gives a brief update regarding the latest technological advancement in the photocoagulation laser therapy market and effective collaboration among niche players. The fundamental players in the diabetic macular edema treatment market are Allergan, Inc., Quantel-Medical, Alimera Sciences, Bausch and Lomb Incorporated, Carl Zeiss Meditec AG, Ellex, Genetech, Inc., IRIDEX Corporation, LUMENIS, Novartis AG, and Regeneron Pharmaceuticals, Inc.

Diabetic macular edema is a complication seen in patients suffering with diabetic retinopathy in which the blood vessels of macula region of retina are damaged and allows the fluid to escape. It is prevalent in two forms as focal diabetic macular edema which employs surgical treatment options and diffuse macular edema which is taken care by drug therapy. Photocoagulation laser therapy is utilized as a standard treatment protocol in patients suffering with blurred visions and double visions. The yellow pattern 577 nm micropulse laser is preferred to the conventional green pattern 532 wavelength due to less thermal absorption by the xanthophyll pigments. Post 2005 the anti-VEGF drug treatment has been considered as the first line of treatment for diabetic macular edema as it inhibits various isoforms of VEGF thus enhancing vision and preventing blindness. Intravitreal implants will be the trendsetter during the forecast duration 2020-2030; Retisert, Illuvien and Ozurdex will provide high drug efficacy and safety. The prominent players in diabetic macular edema treatment market are Allergan, Inc., Alimera Sciences, Bausch and Lomb Incorporated, Carl Zeiss Meditec AG, Ellex, Genetech, Inc., IRIDEX Corporation, LUMENIS, Novartis AG, Quantel-Medical and Regeneron Pharmaceuticals, Inc.

As per the research finding of Center for Disease Control and Prevention 2019, there were around 4.2 million people suffering with diabetic retinopathy with 655,000 of them suffering with diabetic retinopathy. The increasing number of U.S. citizens being diagnosed for type 2 diabetes and the recent USFDA approval for intravitreal implants such as Iluvien, Eylea and Ozurdex will contribute to the assist the growth of North American diabetic macular edema treatment market. The Western European region shows remarkable growth in the diabetic macular edema treatment market due to presence of cardinal players and prolific investment in the research and development segment to develop intravitreal implants. Asia Pacific reflects a balanced growth as a result of the competitive market created by the global and domestic manufacturers of photocoagulation lasers. In addition the supportive regulatory environment for the drug therapies and intravitreal implants have a positive impact on Asia Pacific market. Proactive role played by government healthcare agencies to promote eyecare and increasing eyesight awareness campaign conducted by major players will thrust the diabetic macular edema treatment market growth in the Middle East and Latin America.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Diabetic Macular Edema Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Diabetic Macular Edema Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

Drugs

Anti-VEGF

Ranibizumab

Aflibercept

Corticosteroids

Fluocinolone Acetonide

Dexamethasone

Others (Triamcinolone Acetonide, Bevacizumab)

Surgery

Photocoagulation Laser Therapy

Intravitreal Implants

Pipeline Analysis

Phase III Drugs

Conbercept

Pemofibrate

O.3mg Ranibizumab Intravitreal Injection

2mg Aflibercept Intravitreal Injection

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

Pre COVID-19 situation

Post COVID-19 situation

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Diabetic Macular Edema Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Diabetic Macular Edema Treatment market?

Which is the largest regional market for Diabetic Macular Edema Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Diabetic Macular Edema Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Diabetic Macular Edema Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Diabetic Macular Edema Treatment Market
  • 2.2. Global Diabetic Macular Edema Treatment Market, By Treatment, 2021 (US$ Million)
  • 2.3. Global Diabetic Macular Edema Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Diabetic Macular Edema Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Diabetic Macular Edema Treatment Market Vendors
  • 3.2. Strategies Adopted by Diabetic Macular Edema Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Diabetic Macular Edema Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Diabetic Macular Edema Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Drugs
      • 5.3.1.1. Anti-VEGF
        • 5.3.1.1.1. Ranibizumab
        • 5.3.1.1.2. Aflibercept
      • 5.3.1.2. Corticosteroids
        • 5.3.1.2.1. Fluocinolone Acetonide
        • 5.3.1.2.2. Dexamethasone
      • 5.3.1.3. Others (Triamcinolone Acetonide, Bevacizumab)
    • 5.3.2. Surgery
      • 5.3.2.1. Photocoagulation Laser Therapy
      • 5.3.2.2. Intravitreal Implants
    • 5.3.3. Pipeline Analysis
      • 5.3.3.1. Phase III Drugs
      • 5.3.3.2. Conbercept
      • 5.3.3.3. Pemofibrate
      • 5.3.3.4. O.3mg Ranibizumab Intravitreal Injection
      • 5.3.3.5. 2mg Aflibercept Intravitreal Injection

6. North America Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 6.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

7. UK and European Union Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 7.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

8. Asia Pacific Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 8.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

9. Latin America Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 9.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

10. Middle East and Africa Diabetic Macular Edema Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 10.3.Diabetic Macular Edema Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Diabetic Macular Edema Treatment Market: By Treatment, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Allergan, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Alimera Sciences
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Bausch and Lomb Incorporated
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Carl Zeiss Meditec AG
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Ellex
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Genetech, Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. IRIDEX Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. LUMENIS
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Novartis AG
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Quantel-Medical
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives
  • 11.11. Regeneron Pharmaceuticals, Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Portfolio
    • 11.11.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 2 Global Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 3 Global Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 4 Global Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 5 Global Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 6 Global Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 7 North America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 8 North America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 9 North America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 10 North America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 11 North America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 12 North America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 13 U.S. Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 14 U.S. Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 15 U.S. Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 16 U.S. Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 17 U.S. Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 18 U.S. Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 19 Canada Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 20 Canada Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 21 Canada Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 22 Canada Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 23 Canada Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 24 Canada Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 25 Rest of North America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 26 Rest of North America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 27 Rest of North America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 28 Rest of North America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 29 Rest of North America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 30 Rest of North America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 31 UK and European Union Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 32 UK and European Union Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 33 UK and European Union Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 34 UK and European Union Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 35 UK and European Union Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 36 UK and European Union Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 37 UK Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 38 UK Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 39 UK Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 40 UK Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 41 UK Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 42 UK Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 43 Germany Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 44 Germany Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 45 Germany Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 46 Germany Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 47 Germany Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 48 Germany Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 49 Spain Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 50 Spain Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 51 Spain Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 52 Spain Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 53 Spain Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 54 Spain Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 55 Italy Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 56 Italy Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 57 Italy Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 58 Italy Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 59 Italy Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 60 Italy Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 61 France Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 62 France Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 63 France Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 64 France Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 65 France Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 66 France Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 67 Rest of Europe Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 68 Rest of Europe Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 69 Rest of Europe Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 70 Rest of Europe Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 71 Rest of Europe Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 72 Rest of Europe Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 73 Asia Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 74 Asia Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 75 Asia Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 76 Asia Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 77 Asia Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 78 Asia Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 79 China Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 80 China Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 81 China Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 82 China Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 83 China Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 84 China Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 85 Japan Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 86 Japan Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 87 Japan Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 88 Japan Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 89 Japan Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 90 Japan Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 91 India Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 92 India Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 93 India Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 94 India Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 95 India Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 96 India Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 97 Australia Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 98 Australia Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 99 Australia Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 100 Australia Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 101 Australia Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 102 Australia Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 103 South Korea Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 104 South Korea Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 105 South Korea Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 106 South Korea Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 107 South Korea Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 108 South Korea Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 109 Latin America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 110 Latin America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 111 Latin America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 112 Latin America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 113 Latin America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 114 Latin America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 115 Brazil Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 116 Brazil Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 117 Brazil Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 118 Brazil Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 119 Brazil Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 120 Brazil Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 121 Mexico Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 122 Mexico Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 123 Mexico Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 124 Mexico Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 125 Mexico Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 126 Mexico Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 127 Rest of Latin America Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 128 Rest of Latin America Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 129 Rest of Latin America Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 130 Rest of Latin America Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 131 Rest of Latin America Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 132 Rest of Latin America Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 133 Middle East and Africa Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 134 Middle East and Africa Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 135 Middle East and Africa Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 136 Middle East and Africa Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 137 Middle East and Africa Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 138 Middle East and Africa Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 139 GCC Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 140 GCC Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 141 GCC Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 142 GCC Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 143 GCC Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 144 GCC Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 145 Africa Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 146 Africa Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 147 Africa Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 148 Africa Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 149 Africa Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 150 Africa Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)
  • TABLE 151 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 152 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Drugs, 2020-2030, USD (Million)
  • TABLE 153 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Anti-VEGF, 2020-2030, USD (Million)
  • TABLE 154 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Corticosteroids, 2020-2030, USD (Million)
  • TABLE 155 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Surgery, 2020-2030, USD (Million)
  • TABLE 156 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market By Pipeline Analysis, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Diabetic Macular Edema Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Diabetic Macular Edema Treatment Market: Quality Assurance
  • FIG. 5 Global Diabetic Macular Edema Treatment Market, By Treatment, 2021
  • FIG. 6 Global Diabetic Macular Edema Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Diabetic Macular Edema Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Diabetic Macular Edema Treatment Market Players, 2021
  • FIG. 9 Global Diabetic Macular Edema Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Diabetic Macular Edema Treatment Market, By Treatment, 2021 Vs 2030, %
  • FIG. 11 U.S. Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Diabetic Macular Edema Treatment Market (US$ Million), 2020 - 2030